(Q34406958)

2 August 2017

1 reference

title

Tumour necrosis factor and lymphotoxin: molecular aspects and role in tissue-specific autoimmunity. (English)

1 reference

2 August 2017

0 references

Körner H

1

1 reference

2 August 2017

Sedgwick JD

series ordinal

2

1 reference

2 August 2017

publication date

1 October 1996

1 reference

Immunology & Cell Biology

2 August 2017

published in

1 reference

2 August 2017

volume

74

1 reference

2 August 2017

issue

5

1 reference

2 August 2017

page(s)

465-472

1 reference

An endotoxin-induced serum factor that causes necrosis of tumors

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes.

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

Hypertriglyceridemia associated with Trypanosoma brucei brucei infection in rabbits: role of defective triglyceride removal.

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

Studies of endotoxin-induced decrease in lipoprotein lipase activity

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

Lipoprotein lipase suppression in 3T3-L1 cells by an endotoxin-induced mediator from exudate cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

Unraveling function in the TNF ligand and receptor families

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

A macrophage factor inhibits adipocyte gene expression: an in vitro model of cachexia

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

Identity of tumour necrosis factor and the macrophage-secreted factor cachectin

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

Molecular cloning of the complementary DNA for human tumor necrosis factor.

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

The genes for tumor necrosis factor (TNF-alpha) and lymphotoxin (TNF-beta) are tandemly arranged on chromosome 17 of the mouse.

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

Lymphotoxin beta, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

Tumour necrosis factor and lymphotoxin genes map close to H–2D in the mouse major histocompatibility complex

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

Linkage map of the human major histocompatibility complex including the tumor necrosis factor genes

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

Guilt by association: HLA-B27 and ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

Vascular cell adhesion molecule-1 modulation by tumor necrosis factor in experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

Lymphocyte Cytotoxicity in vitro: Activation and Release of a Cytotoxic Factor

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

Cytotoxicity mediated by soluble antigen and lymphocytes in delayed hypersensitivity. II. Correlation of the in vitro response with skin reactivity

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

Cytotoxic Effect of Lymphocyte-Antigen Interaction in Delayed Hypersensitivity

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

Cytotoxicity mediated by soluble antigen and lymphocytes in delayed hypersensitivity. I. Characterization of the phenomenon

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activity

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

A novel addition to the T cell repertory. Cell surface expression of tumor necrosis factor/cachectin by activated normal human T cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

Functional discrepancies between tumor necrosis factor and lymphotoxin alpha explained by trimer stability and distinct receptor interactions.

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

Role of lymphotoxin and the type I TNF receptor in the formation of germinal centers

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

Characterization of receptors for human tumour necrosis factor and their regulation by gamma-interferon

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

Dual role of the p75 tumor necrosis factor (TNF) receptor in TNF cytotoxicity.

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

The 26-kD transmembrane form of tumor necrosis factor alpha on activated CD4+ T cell clones provides a costimulatory signal for human B cell activation

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

Matrix metalloproteinases and processing of pro-TNF-alpha.

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

A lymphotoxin-beta-specific receptor

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

Experimental allergic encephalomyelitis in the absence of a classical delayed-type hypersensitivity reaction. Severe paralytic disease correlates with the presence of interleukin 2 receptor-positive cells infiltrating the central nervous system

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

Loss of encephalitogenicity of a myelin basic protein-specific T cell line is associated with a phenotypic change but not with alteration in production of interleukin-2, γ-interferon or tumour necrosis factor

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

Anti?tumor necrosis factor therapy abrogates autoimmune demyelination

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

Prevention of chronic relapsing experimental autoimmune encephalomyelitis by soluble tumor necrosis factor receptor I

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

Inhibition of tumor necrosis factor activity minimizes target organ damage in experimental autoimmune uveoretinitis despite quantitatively normal activated T cell traffic to the retina

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

Mechanism and biological significance of CD4-mediated cytotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

Fas and Fas ligand: a death factor and its receptor.

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

Metalloproteinase-mediated release of human Fas ligand

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

A novel domain within the 55 kd TNF receptor signals cell death

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

Self-association of the Death Domains of the p55 Tumor Necrosis Factor (TNF) Receptor and Fas/APO1 Prompts Signaling for TNF and Fas/APO1 Effects

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

Induction of apoptosis in mature T cells by tumour necrosis factor

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

Apoptosis in the nervous system in experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

Identification and characterization of a new member of the TNF family that induces apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FICB.1996.77

7 January 2021

Identifiers

DOI

10.1038/ICB.1996.77

1 reference

2 August 2017

1 reference